A5101796237- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare cost, quality, practices
- Pharmaceutical studies and practices
- Global trade and economics
- Healthcare Quality and Management
- Clinical practice guidelines implementation
- Patient Satisfaction in Healthcare
- Atrial Fibrillation Management and Outcomes
- Malaria Research and Control
University of Technology Sydney
2014-2018
Royal North Shore Hospital
2016
Civil Hospital Karachi
1934
Objective: To identify how 'elderly' patients are defined and considered within Australian clinical guidelines for the use of pharmacotherapy.Method: Guidelines pertaining to pharmacotherapy, focusing on conditions described in National Health Priority Areas, were identified using databases (Medline, Google Scholar) organisation websites (Department Ageing, Heart Foundation, Medical Research Council).Guidelines reviewed qualitatively analysed any references or definitions persons.Results:...
The safety of pharmacotherapy in atrial fibrillation (AF) is compounded by a trilogy risks old age, high-risk medications (e.g., antithrombotics, antiarrhythmics), polypharmacy due to multiple patient comorbidities. However, date, scarce study has investigated the use (including potentially inappropriate medication (PIM)) AF patients, and how this may contribute their overall risk misadventure.To review extent PIM older patients (65 years or older) with AF.Information was extracted from...
Abstract Background To date, there is no national or international consensus on which key performance indicators ( KPIs ) should be used to measure hospital pharmacy performance. Aim explore pharmacists’ perspectives the role of and use their suggest a set for in Australian practice. Methods The study comprised two parts. Part A involved semi‐structured interviews with pharmacists from major Sydney metropolitan hospitals; were conducted until theme saturation was attained. B an online survey...